Tetra Discovery Partners Initiates Phase 2 Clinical Trial of BPN14770 in Patients with Early Alzheimer’s Disease
— Trial to evaluate effects of selective inhibitor of phosphodiesterase-4D on memory and cognitive measures — GRAND RAPIDS, Mich.–(BUSINESS WIRE)–Tetra…